ZA919260B - Chimeric fibroblast growth factor - Google Patents
Chimeric fibroblast growth factorInfo
- Publication number
- ZA919260B ZA919260B ZA919260A ZA919260A ZA919260B ZA 919260 B ZA919260 B ZA 919260B ZA 919260 A ZA919260 A ZA 919260A ZA 919260 A ZA919260 A ZA 919260A ZA 919260 B ZA919260 B ZA 919260B
- Authority
- ZA
- South Africa
- Prior art keywords
- fibroblast growth
- growth factor
- chimeric
- fgf
- fgfs
- Prior art date
Links
- 108050007372 Fibroblast Growth Factor Proteins 0.000 title abstract 5
- 102000018233 Fibroblast Growth Factor Human genes 0.000 title abstract 5
- 229940126864 fibroblast growth factor Drugs 0.000 title 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 3
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 abstract 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 abstract 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 2
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 235000018417 cysteine Nutrition 0.000 abstract 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 101000846416 Homo sapiens Fibroblast growth factor 1 Proteins 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 abstract 1
- 230000002297 mitogenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61520290A | 1990-11-23 | 1990-11-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA919260B true ZA919260B (en) | 1992-08-26 |
Family
ID=24464425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA919260A ZA919260B (en) | 1990-11-23 | 1991-11-22 | Chimeric fibroblast growth factor |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US5310883A (el) |
| EP (1) | EP0486862B1 (el) |
| JP (1) | JP3205578B2 (el) |
| KR (1) | KR100205078B1 (el) |
| AT (1) | ATE138687T1 (el) |
| AU (1) | AU646514B2 (el) |
| CA (1) | CA2055963C (el) |
| DE (1) | DE69119869T2 (el) |
| DK (1) | DK0486862T3 (el) |
| ES (1) | ES2087207T3 (el) |
| GR (1) | GR3020237T3 (el) |
| IE (1) | IE74956B1 (el) |
| IL (1) | IL99984A (el) |
| NZ (1) | NZ240622A (el) |
| PT (1) | PT99565B (el) |
| ZA (1) | ZA919260B (el) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7252929B2 (en) | 1989-02-09 | 2007-08-07 | United States Of America, As Represented By The Secretary, Dept Of Health & Human Services | Methods for identifying alpha PDGFR agonists and antagonists |
| US5951972A (en) * | 1990-05-04 | 1999-09-14 | American Cyanamid Company | Stabilization of somatotropins and other proteins by modification of cysteine residues |
| ES2087207T3 (es) * | 1990-11-23 | 1996-07-16 | American Cyanamid Co | Factor del crecimiento de fibroblasto quimerico. |
| US5206354A (en) * | 1990-11-23 | 1993-04-27 | American Cyanamid Company | Dna sequence encoding active fragment of fibroblast growth factor, hbf-2 |
| KR100374310B1 (ko) * | 1995-02-14 | 2003-05-22 | 주식회사 엘지생명과학 | 변형된인간염기성섬유아세포성장인자및이의생산방법 |
| EP0880598A4 (en) * | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| IL125756A (en) | 1996-02-15 | 2003-05-29 | Biosense Inc | Catheter for use in surgery |
| US6927287B1 (en) * | 1996-06-03 | 2005-08-09 | United States Surgical Corporation | Nucleic acid encoding extracellular matrix protein or fragment thereof |
| US6492508B1 (en) * | 1996-06-03 | 2002-12-10 | United States Surgical Corp. A Division Of Tyco Healthcare Group | Nucleic acids encoding extracellular matrix proteins |
| US6443974B1 (en) | 1996-07-28 | 2002-09-03 | Biosense, Inc. | Electromagnetic cardiac biostimulation |
| US20030144202A1 (en) * | 1996-10-15 | 2003-07-31 | Amgen Inc. | Uses of keratinocyte growth factor-2 |
| US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
| US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
| US20030129750A1 (en) * | 1998-02-05 | 2003-07-10 | Yitzhack Schwartz | Homing of donor cells to a target zone in tissue using active therapeutics or substances |
| US20030113303A1 (en) * | 1998-02-05 | 2003-06-19 | Yitzhack Schwartz | Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances |
| DE69838526T2 (de) | 1998-02-05 | 2008-07-03 | Biosense Webster, Inc., Diamond Bar | Gerät zum Freisetzen eines Medikaments im Herzen |
| CN1379681A (zh) * | 1998-04-17 | 2002-11-13 | 安乔格尼克斯公司 | 治疗性的血管生成因子及其使用方法 |
| US5929051A (en) * | 1998-05-13 | 1999-07-27 | Carrington Laboratories, Inc. | Aloe pectins |
| US7022683B1 (en) | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
| US6313103B1 (en) | 1998-05-13 | 2001-11-06 | Carrington Laboratories, Inc. | Pectic substance as a growth factor stabilizer |
| US6440934B1 (en) | 1998-10-13 | 2002-08-27 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
| EP1121141A2 (en) | 1998-10-13 | 2001-08-08 | Chiron Corporation | Angiogenically effective unit dose of fgf and method of administering |
| US8618052B2 (en) | 1998-10-13 | 2013-12-31 | Novartis Vaccines And Diagnostics, Inc. | Method of treating coronary artery disease by administering FGF-5 |
| US20020072489A1 (en) * | 1998-10-13 | 2002-06-13 | Whitehouse Martha J. | Angiogenically effective unit dose of FGF-2 and method of use |
| US20030166550A1 (en) | 1999-08-27 | 2003-09-04 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
| WO2001013031A2 (en) * | 1999-08-13 | 2001-02-22 | Chiron Corporation | Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| US7494669B2 (en) | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| IL149562A0 (en) * | 2002-05-09 | 2002-11-10 | Prochon Ltd | Fgf variants and methods for use thereof |
| US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
| CA2623106C (en) | 2005-09-19 | 2013-12-24 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
| US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
| US20090054984A1 (en) | 2007-08-20 | 2009-02-26 | Histogenics Corporation | Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects |
| US8685107B2 (en) | 2007-07-03 | 2014-04-01 | Histogenics Corporation | Double-structured tissue implant and a method for preparation and use thereof |
| EP2265220A1 (en) | 2008-03-05 | 2010-12-29 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| WO2009132457A1 (en) * | 2008-05-02 | 2009-11-05 | University Of Western Ontario | Fgf-9 and its use relating to blood vessels |
| US9169309B2 (en) * | 2011-03-01 | 2015-10-27 | Humanzyme Inc. | Thermostable variants of fibroblast growth factors |
| US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
| CN105859892A (zh) * | 2016-06-08 | 2016-08-17 | 浙江大学 | 一种类胶原蛋白-人碱性成纤维细胞生长因子融合蛋白及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4296100A (en) * | 1980-06-30 | 1981-10-20 | Franco Wayne P | Method of treating the heart for myocardial infarction |
| US4378347A (en) * | 1980-06-30 | 1983-03-29 | Franco Wayne P | Composition for treating the heart for myocardial infarction |
| US4588585A (en) * | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
| US4518584A (en) * | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| US4785079A (en) * | 1984-11-09 | 1988-11-15 | The Salk Institute For Biological Studies | Isolation of fibroblast growth factor |
| US4956455A (en) * | 1984-03-05 | 1990-09-11 | The Salk Institute For Biological Studies | Bovine fibroblast growth factor |
| US4959314A (en) * | 1984-11-09 | 1990-09-25 | Cetus Corporation | Cysteine-depleted muteins of biologically active proteins |
| US4902782A (en) * | 1986-12-10 | 1990-02-20 | The Salk Institute For Biological Studies | Isolation of fibroblast growth factor |
| JP2879148B2 (ja) * | 1987-07-07 | 1999-04-05 | サイオス インコーポレイテッド | 組換え繊維芽細胞成長因子 |
| JPH02504468A (ja) * | 1987-11-24 | 1990-12-20 | アムジエン・インコーポレーテツド | 繊維芽細胞成長因子のアナログ |
| US5130418A (en) * | 1989-05-02 | 1992-07-14 | California Biotechnology Inc. | Method to stabilize basic fibroblast growth factor |
| ES2087207T3 (es) * | 1990-11-23 | 1996-07-16 | American Cyanamid Co | Factor del crecimiento de fibroblasto quimerico. |
| CA2259333A1 (en) * | 1996-06-29 | 1998-01-08 | Dieter Muller | Pharmaceutical administration form |
-
1991
- 1991-11-04 ES ES91118725T patent/ES2087207T3/es not_active Expired - Lifetime
- 1991-11-04 DK DK91118725.0T patent/DK0486862T3/da active
- 1991-11-04 US US07/783,694 patent/US5310883A/en not_active Expired - Lifetime
- 1991-11-04 EP EP91118725A patent/EP0486862B1/en not_active Expired - Lifetime
- 1991-11-04 AT AT91118725T patent/ATE138687T1/de not_active IP Right Cessation
- 1991-11-04 DE DE69119869T patent/DE69119869T2/de not_active Expired - Fee Related
- 1991-11-07 IL IL9998491A patent/IL99984A/en active IP Right Grant
- 1991-11-18 NZ NZ240622A patent/NZ240622A/en not_active IP Right Cessation
- 1991-11-21 CA CA002055963A patent/CA2055963C/en not_active Expired - Fee Related
- 1991-11-21 JP JP33156891A patent/JP3205578B2/ja not_active Expired - Fee Related
- 1991-11-21 PT PT99565A patent/PT99565B/pt not_active IP Right Cessation
- 1991-11-22 AU AU88062/91A patent/AU646514B2/en not_active Ceased
- 1991-11-22 ZA ZA919260A patent/ZA919260B/xx unknown
- 1991-11-22 IE IE406891A patent/IE74956B1/en not_active IP Right Cessation
- 1991-11-22 KR KR1019910021053A patent/KR100205078B1/ko not_active IP Right Cessation
-
1993
- 1993-02-26 US US08/023,757 patent/US5302702A/en not_active Expired - Lifetime
-
1994
- 1994-01-05 US US08/177,502 patent/US5371206A/en not_active Expired - Lifetime
-
1996
- 1996-06-17 GR GR950403456T patent/GR3020237T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT99565A (pt) | 1992-10-30 |
| CA2055963C (en) | 2002-11-12 |
| GR3020237T3 (en) | 1996-09-30 |
| IL99984A0 (en) | 1992-08-18 |
| JPH04330097A (ja) | 1992-11-18 |
| NZ240622A (en) | 1994-08-26 |
| EP0486862B1 (en) | 1996-05-29 |
| IE74956B1 (en) | 1997-08-13 |
| JP3205578B2 (ja) | 2001-09-04 |
| EP0486862A1 (en) | 1992-05-27 |
| ATE138687T1 (de) | 1996-06-15 |
| IE914068A1 (en) | 1992-06-03 |
| CA2055963A1 (en) | 1992-05-24 |
| US5371206A (en) | 1994-12-06 |
| IL99984A (en) | 1998-12-06 |
| DE69119869T2 (de) | 1996-12-12 |
| PT99565B (pt) | 1999-04-30 |
| KR920009848A (ko) | 1992-06-25 |
| ES2087207T3 (es) | 1996-07-16 |
| KR100205078B1 (ko) | 1999-06-15 |
| DE69119869D1 (de) | 1996-07-04 |
| AU8806291A (en) | 1992-05-28 |
| DK0486862T3 (da) | 1996-06-24 |
| AU646514B2 (en) | 1994-02-24 |
| US5302702A (en) | 1994-04-12 |
| US5310883A (en) | 1994-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3020237T3 (en) | Chimeric fibroblast growth factor | |
| ATE491029T1 (de) | Fibroblasten-wachstumsfaktoren-homologe | |
| DE69333243D1 (de) | Mutierte polypeptide des interleukin-3(il-3) | |
| ATE458054T1 (de) | Menschliches parathyroidhormon, modifikationen, herstellung und verwendung | |
| AU2310995A (en) | Peptide fragment of the respiratory syncytial virus protein g, immunogenic agent, pharmaceutical composition containing it and preparation process | |
| SI20643B (sl) | IL-2-selektivni agonisti in antagonisti | |
| IS2518B (is) | Lífvirk peptíð, not fyrir þau og vinnsla þeirra | |
| GB8727045D0 (en) | Immunoglobulin e competitor | |
| GR3031927T3 (en) | Cysteine depleted il-6 muteins | |
| EP1501936A4 (en) | PROTEIN FAMILY OF CYTOKINE | |
| HUT61486A (en) | Implant composition comprising biologically active protein, peptide or polypeptide | |
| SE8801723D0 (sv) | Fibronectin binding protein as well as its preparation | |
| ATE140234T1 (de) | Neue inhibitorische peptide | |
| GR3020507T3 (en) | New peptide derivatives, process to prepare them and their use as medicaments | |
| Seddon et al. | DNA encoding chimeric fibroblast growth factors |